Cabaletta Bio, Inc. Analyst EPS Estimates
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 2 | -$0.55 | -$0.55 | -$0.55 |
Q2 2024 | 2 | -$0.60 | -$0.60 | -$0.60 |
Q3 2024 | 6 | -$0.68 | -$0.53 | -$0.62 |
Q1 2025 | 3 | -$0.69 | -$0.67 | -$0.68 |
Q2 2025 | 2 | -$0.71 | -$0.71 | -$0.71 |
Q3 2025 | 2 | -$0.73 | -$0.73 | -$0.73 |
Q4 2025 | 2 | -$0.69 | -$0.69 | -$0.69 |
Q1 2026 | 1 | -$0.80 | -$0.80 | -$0.80 |
Q2 2026 | 1 | -$0.84 | -$0.84 | -$0.84 |
Q3 2026 | 1 | -$0.85 | -$0.85 | -$0.85 |
Q4 2026 | 1 | -$0.88 | -$0.88 | -$0.88 |
Cabaletta Bio, Inc. Earnings Date And Information
Cabaletta Bio, Inc. last posted its earnings results on Thursday, November 14th, 2024. The company reported $-0.62 earnings per share for the quarter, missing analysts' consensus estimates of $-0.59 by $0.03. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Cabaletta Bio, Inc. has generated $-2 earnings per share over the last year ($-1.65 diluted earnings per share) and currently has a price-to-earnings ratio of -0.88. Cabaletta Bio, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 13th, 2025 based on prior year's report dates.
Cabaletta Bio, Inc. Earnings History by Quarter
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
11/14/2024 | Q3 2024 | -$0.59 | -$0.63 | -0.04 | $0 | $0 |
08/08/2024 | Q2 2024 | -$0.55 | -$0.56 | -0.01 | $0 | $0 |
05/15/2024 | Q1 2024 | -$0.48 | -$0.51 | -0.03 | $0 | |
03/21/2024 | Q4 2023 | -$0.39 | -$0.47 | -0.08 | $4.01 M | |
11/09/2023 | Q3 2023 | -$0.39 | -$0.37 | 0.02 | $0 | |
08/10/2023 | Q2 2023 | -$0.47 | -$0.37 | 0.1 | $0 | |
05/11/2023 | Q1 2023 | -$0.48 | -$0.42 | 0.06 | $0 | |
03/16/2023 | Q4 2022 | -$0.47 | -$0.51 | -0.04 | $0 | |
11/10/2022 | Q3 2022 | -$0.49 | -$0.38 | 0.11 | $0 | |
08/11/2022 | Q2 2022 | -$0.52 | -$0.44 | 0.08 | $0 | |
05/12/2022 | Q1 2022 | -$0.64 | -$0.45 | 0.19 | $0 | |
03/17/2022 | Q4 2021 | -$0.68 | -$0.49 | 0.19 | $0 | |
11/01/2021 | Q3 2021 | -$0.52 | -$0.45 | 0.07 | $0 | |
08/05/2021 | Q2 2021 | -$0.51 | -$0.55 | -0.04 | $0 | |
05/03/2021 | Q1 2021 | -$0.49 | -$0.51 | -0.02 | $0 | |
03/16/2021 | Q4 2020 | -$0.34 | -$0.40 | -0.06 | $0 | |
11/10/2020 | Q3 2020 | -$0.47 | -$0.36 | 0.11 | $0 | |
08/06/2020 | Q2 2020 | -$0.45 | -$0.35 | 0.1 | $0 | |
05/12/2020 | Q1 2020 | -$0.23 | -$0.33 | -0.1 | $0 | |
03/30/2020 | Q4 2019 | -$0.65 | -$0.22 | 0.43 | $0 |
Cabaletta Bio, Inc. Earnings: Frequently Asked Questions
-
When is Cabaletta Bio, Inc.'s earnings date?
Cabaletta Bio, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 13th, 2025 based off last year's report dates.
-
How can I listen to Cabaletta Bio, Inc.'s earnings conference call?
The conference call for Cabaletta Bio, Inc.'s latest earnings report can be listened to online.
-
How can I read Cabaletta Bio, Inc.'s conference call transcript?
The conference call transcript for Cabaletta Bio, Inc.'s latest earnings report can be read online.
-
How much profit does Cabaletta Bio, Inc. generate each year?
Cabaletta Bio, Inc. (:CABA) has a recorded net income of $0. Cabaletta Bio, Inc. has generated $-1.65 earnings per share over the last four quarters.
-
What is Cabaletta Bio, Inc.'s price-to-earnings ratio?
Cabaletta Bio, Inc. (:CABA) has a price-to-earnings ratio of -0.88 and price/earnings-to-growth ratio is 0.06.